.Cognition Therapeutics' period 2 sparkle trial has actually taken some of the appeal off the Alzhei...
.Bristol Myers Squibb has had a whiplash change of heart on its BCMA bispecific T-cell engager, stop...
.Charles Baum, M.D., Ph.D., who managed Mirati Therapies' $ 5.8 billion purchase to Bristol Myers Sq...
.After reaching out to much more than 200 firms to partner a Tourette disorder treatment that presen...
.Novartis has actually had some bad luck with bispecific antitoxins in the past, however evaluating ...
.Pinetree Therapeutics will aid AstraZeneca vegetation some plants in its pipe along with a brand ne...
.GRO Biosciences has ended the full week with an added $60.3 thousand in the bank, which the protein...
.Invite to this week's Chutes & Ladders, our summary of considerable management hirings, shooting...